Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
239
NCT05600114
Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 27, 2022
Completion: Dec 13, 2023